Stock listing
Lang & Schwarz:A41YN5 Oncoinvent ASA Aktie
German listing (Lang & Schwarz) of Oncoinvent ASA · home listing Oslo:ONCIN
Follow Oncoinvent ASA into a list and get an email when it puts out news.
Home listing price · OSL:ONCIN
69.00 NOK -0.80 (-1.1%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OSL:ONCIN
- Day range
- 68.40 – 71.00 NOKOct 30, 2026
- Volume
- 8,846 sharesOct 30, 2026
- Market cap
- 422.9M NOKAt the close on Oct 30, 2026 · price × 6.13M shares outstanding
- 52-week range
- 40.10 – 144.00 NOKLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- 3.39M NOKMedian day 13,695 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Oslo:ONCIN · Home | 69.00 NOK | -0.80 (-1.1%) | 8,846 | 71.00 | 71.00 | 68.40 | 69.80 | Close on Oct 30, 2026 |
| LSE:0RU5 | 66.40 NOK | -0.20 (-0.3%) | 2 | 66.40 | 66.40 | 66.40 | 66.60 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OSL:ONCIN · NOK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 69.00 | -0.80 | -1.1% | 71.00 | 71.00 | 68.40 | 8,846 | |
| 69.80 | +1.20 | +1.7% | 71.00 | 71.00 | 67.60 | 7,392 | |
| 68.60 | +0.40 | +0.6% | 70.00 | 70.80 | 68.40 | 11,624 | |
| 68.20 | 0.00 | 0.0% | 68.20 | 68.80 | 66.40 | 20,856 | |
| 68.20 | +1.20 | +1.8% | 67.00 | 71.60 | 65.40 | 24,631 | |
| 67.00 | 0.00 | 0.0% | 67.00 | 68.00 | 66.20 | 12,242 | |
| 67.00 | 0.00 | 0.0% | 67.00 | 67.00 | 64.80 | 19,229 | |
| 67.00 | -1.20 | -1.8% | 68.40 | 68.80 | 67.00 | 5,908 | |
| 68.20 | +0.80 | +1.2% | 67.60 | 68.20 | 66.40 | 5,513 | |
| 67.40 | -0.80 | -1.2% | 68.00 | 69.40 | 66.00 | 12,502 | |
| 68.20 | +0.20 | +0.3% | 68.40 | 71.60 | 66.80 | 17,997 | |
| 68.00 | -0.60 | -0.9% | 68.40 | 68.60 | 66.00 | 27,708 | |
| 68.60 | -1.40 | -2.0% | 68.20 | 70.60 | 68.20 | 5,877 | |
| 70.00 | +0.60 | +0.9% | 75.00 | 75.00 | 68.40 | 21,123 | |
| 69.40 | -0.60 | -0.9% | 71.00 | 78.40 | 69.20 | 39,555 | |
| 70.00 | -1.20 | -1.7% | 71.00 | 72.40 | 70.00 | 33,322 | |
| 71.20 | -4.20 | -5.6% | 77.60 | 77.60 | 70.60 | 112,286 | |
| 75.40 | -3.80 | -4.8% | 79.00 | 79.20 | 75.20 | 34,834 | |
| 79.20 | -1.60 | -2.0% | 80.80 | 80.80 | 79.00 | 20,988 | |
| 80.80 | -2.00 | -2.4% | 82.20 | 82.40 | 79.40 | 31,194 | |
| 82.80 | -0.40 | -0.5% | 83.20 | 84.60 | 82.80 | 12,578 | |
| 83.20 | -1.80 | -2.1% | 87.40 | 87.40 | 83.20 | 59,530 | |
| 85.00 | -0.40 | -0.5% | 87.80 | 87.80 | 84.20 | 21,801 | |
| 85.40 | +1.60 | +1.9% | 84.00 | 86.80 | 83.80 | 29,806 | |
| 83.80 | 0.00 | 0.0% | 82.60 | 84.60 | 82.00 | 12,613 | |
| 83.80 | +0.80 | +1.0% | 83.40 | 85.00 | 82.60 | 30,779 | |
| 83.00 | -3.00 | -3.5% | 84.20 | 85.40 | 82.20 | 67,495 | |
| 86.00 | -24.00 | -21.8% | 86.00 | 89.20 | 85.80 | 1,361,000 | |
| 110.00 | -6.00 | -5.2% | 120.00 | 120.00 | 108.00 | 22,260 | |
| 116.00 | -11.50 | -9.0% | 129.00 | 134.50 | 116.00 | 18,183 | |
| 127.50 | -4.50 | -3.4% | 127.50 | 140.00 | 127.00 | 16,637 | |
| 132.00 | -3.00 | -2.2% | 139.00 | 139.00 | 128.50 | 8,410 | |
| 135.00 | +6.00 | +4.7% | 135.00 | 140.00 | 126.50 | 15,779 | |
| 129.00 | -12.50 | -8.8% | 144.00 | 144.00 | 122.50 | 25,273 | |
| 141.50 | +7.00 | +5.2% | 140.00 | 144.00 | 138.00 | 26,767 | |
| 134.50 | +11.00 | +8.9% | 129.50 | 135.00 | 127.50 | 43,791 | |
| 123.50 | +13.50 | +12.3% | 110.00 | 124.50 | 110.00 | 39,408 | |
| 110.00 | +5.50 | +5.3% | 104.50 | 110.00 | 102.00 | 31,158 | |
| 104.50 | +4.50 | +4.5% | 106.00 | 106.00 | 101.50 | 19,696 | |
| 100.00 | +6.20 | +6.6% | 94.40 | 107.00 | 94.40 | 37,146 | |
| 93.80 | +5.20 | +5.9% | 90.00 | 94.60 | 90.00 | 25,264 | |
| 88.60 | -2.40 | -2.6% | 91.00 | 91.00 | 88.40 | 3,994 | |
| 91.00 | +1.80 | +2.0% | 92.80 | 92.80 | 87.00 | 5,728 | |
| 89.20 | -4.40 | -4.7% | 90.00 | 92.80 | 89.00 | 13,695 | |
| 93.60 | +7.00 | +8.1% | 85.20 | 93.60 | 85.20 | 13,702 | |
| 86.60 | -4.40 | -4.8% | 91.80 | 91.80 | 83.20 | 11,294 | |
| 91.00 | -0.20 | -0.2% | 91.40 | 93.80 | 88.00 | 14,642 | |
| 91.20 | +6.20 | +7.3% | 85.20 | 93.40 | 84.20 | 15,304 | |
| 85.00 | +0.80 | +1.0% | 89.00 | 89.00 | 80.20 | 4,401 | |
| 84.20 | +1.00 | +1.2% | 87.00 | 87.00 | 81.60 | 4,300 | |
| 83.20 | +0.80 | +1.0% | 82.40 | 83.60 | 74.60 | 9,466 | |
| 82.40 | -4.40 | -5.1% | 85.00 | 91.00 | 78.00 | 8,748 | |
| 86.80 | -0.40 | -0.5% | 90.20 | 90.20 | 84.80 | 6,339 | |
| 87.20 | -1.00 | -1.1% | 87.00 | 89.20 | 87.00 | 4,280 | |
| 88.20 | -2.20 | -2.4% | 94.00 | 94.00 | 86.00 | 8,971 | |
| 90.40 | +2.40 | +2.7% | 90.60 | 90.60 | 85.80 | 13,486 | |
| 88.00 | +1.60 | +1.9% | 86.00 | 90.00 | 86.00 | 9,550 | |
| 86.40 | +3.20 | +3.8% | 84.80 | 87.00 | 83.40 | 7,137 | |
| 83.20 | +2.00 | +2.5% | 81.00 | 85.00 | 81.00 | 7,542 | |
| 81.20 | -0.80 | -1.0% | 81.80 | 85.00 | 81.00 | 2,588 | |
| 82.00 | +3.80 | +4.9% | 79.80 | 84.00 | 78.00 | 5,068 | |
| 78.20 | +1.20 | +1.6% | 73.00 | 80.00 | 73.00 | 2,857 | |
| 77.00 | -3.20 | -4.0% | 80.20 | 80.20 | 73.00 | 3,207 | |
| 80.20 | -0.80 | -1.0% | 80.00 | 81.00 | 77.20 | 2,876 | |
| 81.00 | -1.00 | -1.2% | 82.00 | 82.00 | 77.00 | 5,972 | |
| 82.00 | -3.60 | -4.2% | 82.00 | 83.60 | 80.60 | 5,292 | |
| 85.60 | -1.20 | -1.4% | 87.80 | 87.80 | 79.40 | 8,147 |
- Ticker
- Lang & Schwarz:A41YN5
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Sep 23, 2026
Oncoinvent ASA - Disclosure of large shareholding
Latest earnings call · Feb 26, 2026
Oncoinvent (Oslo:ONCIN) Q4 2025 Earnings Call
Replay and transcript
Latest deck · Oct 28, 2026
Q3 2026 Earnings Presentation
Earnings · 21 slides
Calls
Replays
Oncoinvent (Oslo:ONCIN) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 4:30 AM ET
Watch TranscriptOncoinvent (Oslo:ONCIN) Q3 2025 Earnings Call
Tue, Nov 04, 2025 · 4:00 AM ET
Watch TranscriptOncoinvent (Oslo:ONCIN) Q4 2024 Earnings Call
Wed, Feb 26, 2025 · 4:30 AM ET
Watch Transcript
Latest news
Oncoinvent ASA - Disclosure of large shareholding
Sep 23, 2026
Closed 86.00 (-21.8%) on Sep 23, 2026
Oncoinvent ASA - Mandatory notification of trade - Allocation and share lending in Private Placement
Sep 22, 2026
Closed 86.00 (-21.8%) on Sep 23, 2026
Oncoinvent ASA - Mandatory notification of trade
Sep 22, 2026
Closed 86.00 (-21.8%) on Sep 23, 2026
Oncoinvent ASA - Key information relating to subsequent offering
Sep 22, 2026
Closed 86.00 (-21.8%) on Sep 23, 2026
Oncoinvent ASA - Successful Private Placement and Retail Offering
Sep 22, 2026
Closed 86.00 (-21.8%) on Sep 23, 2026
Oncoinvent ASA - Contemplated private placement and retail offering
Sep 22, 2026
Closed 86.00 (-21.8%) on Sep 23, 2026
Oncoinvent announces publication of normal tissue dosimetry results in Journal of Nuclear Medicine
Aug 11, 2026
Closed 83.20 (+2.5%) on Aug 11, 2026
Oncoinvent achieves 50% recruitment milestone in Phase 2 ovarian cancer study of Radspherin[®]
Jun 18, 2026
Closed 50.00 (+13.6%) on Jun 18, 2026
Oncoinvent ASA: Grant of share options to member of the Board following AGM
May 20, 2026
Closed 46.50 (-0.6%) on May 21, 2026
Oncoinvent ASA: Share capital decrease completed
May 5, 2026
Closed 48.20 (+0.4%) on May 5, 2026
Financings
Private placement of new shares
Sep 22, 2026 · US$14.59M
Closed: NOK 137.8M raised · NOK 90 a share · ABG Sundal Collier ASA +1
Dealers: ABG Sundal Collier ASA (co-lead), DNB Carnegie (co-lead)
Buyers: Linc AB (Offer Shares for NOK approximately 17.4 million); Hadean Ventures (Offer Shares for approximately NOK 17.3 million); Øystein Soug (Offer Shares for NOK 299,970); Ramzi Amri (Offer Shares for NOK 270,000); Gillies O'Bryan-Tear (Offer Shares for NOK 886,140); Gro Hjellum (Offer Shares for NOK 45,000); Ingrid Akay (Offer Shares for NOK 358,560); Kari Grønås (Offer Shares for NOK 29,880); Hadean Capital I AS (108,469 new shares); HVentures Capital I AB (49,199 new shares); Hadean Growth Fund I AS (34,875 new shares)
Insiders: Hadean Capital I AS, HVentures Capital I AB and Hadean Growth Fund I AS, closely associated with board member Ingrid Teigland Akay, were allocated 192,543 new shares in aggregate
Use of proceeds: Progress and complete Phase 2 ovarian cancer study, FDA/EMA regulatory alignment and Phase 3 IND/CTA submission, Phase 3 readiness
Announced Sep 22, 2026 · Closed Sep 22, 2026 · Update Sep 22, 2026
New shares (subsequent repair offering)
Sep 22, 2026
Update: NOK 90 a share
New shares (retail offering)
Sep 22, 2026 · US$1.13M
Closed: NOK 10.7M raised · Nordnet Bank AB
Dealers: Nordnet Bank AB
Decks
Q3 2026 Earnings Presentation
Earnings · 21 slides · Oct 28, 2026
Investor Presentation (September 2026)
Investor deck · 50 slides · September 2026
H1 2026 Earnings Presentation
Earnings · 17 slides · Aug 27, 2026
Investor Presentation (August 2026)
Investor deck · 30 slides · August 2026
Oncoinvent ASA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 29 in the last 12 months · 32 in all · newest Sep 23, 2026 · oldest 2025
- Calls
- 6 calls with a replay · 6 with a transcript · latest Feb 26, 2026
- Decks
- 26 decks · latest Oct 28, 2026
Where Oncoinvent ASA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Oslo:ONCIN · Home listing | Oslo | Norway | NOK |
| LS Exchange:A41YN5 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A41YN5 · This page | Lang & Schwarz | Germany | EUR |
| LSE:0RU5 | LSE | United Kingdom | NOK |
| OTC:BRRGF | OTC | United States | USD |
| gettex:7BG | gettex | Germany | EUR |
| Aquis:ONCINO | Aquis | United Kingdom | NOK |
| Aquis:ONCINO | Aquis | United Kingdom | NOK |
| Dusseldorf:7BG | Dusseldorf | Germany | EUR |
| Frankfurt:7BG | Frankfurt | Germany | EUR |
| Munich:7BG | Munich | Germany | EUR |
| Stockholm:ONCINO | Stockholm | Sweden | NOK |
| Stuttgart:7BG | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Oncoinvent ASA.